MELISSA RUDGE: Open Payments
NPI 1326520966 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,371 in 89 payments from 12 companies in 2025. Trend: 2023 $495 · 2024 $1,233 · 2025 $1,371
Food & beverage: $1,371
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $725 |
| Supernus Pharmaceuticals, Inc. | 9 | $114 |
| Axsome Therapeutics, Inc. | 4 | $95 |
| Vanda Pharmaceuticals Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $67 |
| Lundbeck LLC | 4 | $66 |
| Alkermes, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $54 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 2 | $36 |
Products named: VRAYLAR, Qelbree, Auvelity, REXULTI, FANAPT, ARISTADA, CAPLYTA, ABILIFY MAINTENA.
Industry payments across PA — which companies pay providers there.
